Blood biomarkers as surrogate endpoints of treatment responses to aerobic exercise and cognitive training (ACT) in amnestic mild cognitive impairment: the blood biomarkers study protocol of a randomized controlled trial (the ACT Trial)

被引:0
作者
Danni Li
Michelle M. Mielke
W. Robert Bell
Cavan Reilly
Lin Zhang
Feng Vankee Lin
Fang Yu
机构
[1] University of Minnesota,Department of Lab Medicine and Pathology
[2] Mayo Clinic College of Medicine,Department of Neurology and Health Sciences Research
[3] University of Minnesota,Division of Biostatistics, School of Public Health
[4] University of Rochester Medical Center,School of Nursing
[5] University of Minnesota,undefined
来源
Trials | / 21卷
关键词
Aerobic exercise; Alzheimer’s disease; Cognitive training; Blood biomarkers; Neuropathological biomarkers; Neurodegenerative biomarkers; Neurotrophic biomarkers; Surrogate endpoints; Treatment responses and amnestic mild cognitive impairment;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 330 条
[1]  
Hebert LE(2018)2018 Alzheimer’s disease facts and figures Alzheimers Dement 14 367-429
[2]  
Weuve J(2013)Alzheimer disease in the United States (2010-2050) estimated using the 2010 census Neurology 80 1778-1783
[3]  
Scherr PA(2019)2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines J Am Coll Cardiol 73 3168-3209
[4]  
Evans DA(2017)Amyloid beta concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis Alzheimers Dement 13 841-849
[5]  
Grundy SM(2018)High performance plasma amyloid-beta biomarkers for Alzheimer’s disease Nature 554 249-254
[6]  
Stone NJ(2018)Plasma phospho-tau181 increases with Alzheimer’s disease clinical severity and is associated with tau- and amyloid-positron emission tomography Alzheimers Dement 14 989-997
[7]  
Bailey AL(2016)Plasma beta-amyloid in Alzheimer’s disease and vascular disease Sci Rep 6 26801-2356
[8]  
Beam C(2018)Longitudinal performance of plasma neurofilament light and tau in professional fighters: the professional fighters brain health study J Neurotrauma 35 2351-1080
[9]  
Birtcher KK(2017)Association of plasma total tau level with cognitive decline and risk of mild cognitive impairment or dementia in the Mayo Clinic study on aging JAMA Neurol 74 1073-1054
[10]  
Blumenthal RS(2018)Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod Mult Scler 24 1046-1856